INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "CANCER TREATMENT WITH A HER2 INHIBITOR AND A CYP3A AND/OR P-GP MODULATOR"

GENEVA, March 17 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2024/074490) for "CANCER TREATMENT WITH A HER2 INHIBITOR AND A CYP3A AND/OR P-GP MODULATOR" on Sep 02, 2024. With publication no. WO/2025/051693, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHAN, Tom Sze-Yin (c/o VP, IP, LegalBoehringer Ingelheim USA Corp.900 Ridgebury Road, P.O. Box 368Ridgefield, Connecticut 06877-0368), GAN, Guanfa (c/o VP, IP, LegalBoehringer Ingelheim USA Corp...